The introduction of ATRA had prompted several study groups to explore the role of ATRA either as a single agent or in combination with chemotherapy. Although treatment with single-agent ATRA ...
ATO was administered for 28 days every 8 weeks and ATRA was administered for 2 weeks ... with no or minimal exposure to conventional DNA-damaging chemotherapy in the majority of patients.
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...
Based on these series of clinical trials, all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) as the front-line treatment has been adopted in all contemporary guidelines since 2013 (18–21). A ...
APL was once a highly fatal disease, with up to 30% of patients dying early from complications. Traditional treatments often ...
Researchers from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) have developed a breakthrough in leukaemia treatment. Their oral formulation of arsenic trioxide (Oral-ATO; Arsenol ...
Considering the safety of the fetus, seven patients in the exposed cohort received low-dose chemotherapy, one patient received all-trans retinoic acid (ATRA) and one patient only received ...
One of those lesser-known struggles is a condition known as chemo mouth, a painful side effect of chemotherapy and radiation. For some, chemo mouth can result in mouth sores and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results